Design
Define the safety, endpoint, operational, patient, device, and vendor signals the trial must generate.
TrialTelemetry.com
Design the signals before the trial exposes the failure.
Trial Telemetry is a practical framework for defining, governing, and routing decision-grade clinical trial signals before first patient in — then using those signals during execution.
Regulatory signal
FDA’s real-time clinical trial announcement changes the consulting conversation.
Consulting lives and dies by relevance to mandates, guidance, and regulatory pressure. The FDA announcement is the public signal that clinical development is moving toward predefined, governed, real-time trial signals — not more end-of-phase data packaging.
The point
Most trial failures do not begin after enrollment starts. They begin earlier: unclear signal definitions, weak endpoint workflows, site burden, vendor handoffs, device logistics, and governance gaps.
If the signal is not designed before FPI, the live trial only reveals the failure later.
Validate
Map each signal to source, workflow, owner, timing, trust gate, and failure mode before launch.
Operate
Detect drift across sites, vendors, systems, patient burden, recruitment, queries, and deviations.
Decide
Preserve traceability so signals can support action, escalation, inspection readiness, and evidence decisions.
Advisory wedge
Pre-FPI Trial Telemetry Review
A focused review for sponsors, CROs, and digital clinical teams that need to find signal-design and workflow failures before the first patient exposes them.
- Protocol signal feasibility
- Endpoint and data-source readiness
- Site workflow burden
- Vendor/system handoffs
- Patient-facing capture risk
- Governance, escalation, traceability
Regulatory fit
Built for the rules that matter.
Trial Telemetry is not a substitute for regulatory strategy, quality systems, validation, monitoring, or sponsor oversight. It is a way to make those requirements operationally visible before the trial is under pressure.
ICH E6(R3)
GCP modernization, risk-based quality management, proportionality, participant protection, and reliable trial results.
ICH E8(R1)
Quality by design: identify critical-to-quality factors during planning, then manage risks during conduct.
21 CFR Part 11
Electronic records, electronic signatures, audit trails, validation, retention, copies, and controlled reliance on electronic data.
21 CFR Part 812
IDE requirements for investigational device studies, including sponsor/investigator responsibilities, records, and reports.
21 CFR Part 820
Device quality-system expectations, including design controls, document controls, purchasing controls, records, CAPA, and traceability.
FDA RTCT
Real-time clinical trials make predefined, governed, traceable signals more important — not less.
Why now
FDA is pointing toward a new operating model.
The service to the reader is simplification: what did FDA announce, what matters, and what does it imply for trial design before FPI?
Open the FDA announcement analysis →Speed without trust is dangerous. Trust without speed is no longer good enough.
Doctrine layer
Operational Telemetry underneath. Trial Telemetry on the clinical trial lifecycle.
Operational Telemetry is the control-tower discipline: ingestion, governance, analysis, and execution. Trial Telemetry applies that discipline from protocol design through launch readiness, real-time operations, and evidence decisions.
Proof arc
Built from operating history, not conference language.
The career arc matters because Trial Telemetry is not just a theory about dashboards. It comes from building patient-facing systems, connected-data workflows, regulated clinical operations, and real-world signal models.
Remote patient telemetry
Philips virtual care lineage
GCP-grade digital clinical operations
PatientStories.ai signal intelligence
Contact
Talk with Kevin about Trial Telemetry.
Useful starting point: a pre-FPI review, protocol signal review, digital endpoint readiness review, or an executive discussion about real-time trial operations.